Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenyang 110016, PR China.
Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenyang 110016, PR China.
Bioorg Chem. 2018 Feb;76:528-537. doi: 10.1016/j.bioorg.2017.12.025. Epub 2017 Dec 30.
A novel series of substituted benzamide derivatives bearing a 1,2,3-triazole moiety were designed and synthesized by click chemistry. Human dihydroorotate dehydrogenase inhibition assay was used to evaluate the synthesized compounds as potent hDHODH inhibitors. Most compounds showed moderate to significant potency, accompanied with a suitable clogD value and compounds 4d, 4o, and 5j effectively inhibited the activity of hDHODH with IC values of 2.1, 2.1 and 1.5 μM, respectively. Compound 4o also effectively suppressed proliferation of the activated PBMCs. The study of structure-activity relationships also revealed that a suitable substitution on para-position of terminal phenyl ring was crucial for high activity. Together, the most promising compound 4o might serve as a novel hDHODH inhibitors for further investigation.
通过点击化学,设计并合成了一系列新型取代苯甲酰胺衍生物,其中含有 1,2,3-三唑部分。采用人二氢乳清酸脱氢酶抑制试验评估合成化合物作为潜在的 hDHODH 抑制剂的活性。大多数化合物表现出中等至显著的活性,同时具有合适的 clogD 值,化合物 4d、4o 和 5j 分别以 2.1、2.1 和 1.5μM 的 IC 值有效抑制 hDHODH 的活性。化合物 4o 还能有效抑制活化的 PBMCs 的增殖。构效关系研究还表明,末端苯环对位的适当取代对于高活性至关重要。总的来说,最有前途的化合物 4o 可能作为一种新型 hDHODH 抑制剂,值得进一步研究。